| Pruitthealth Nutritional Supp | |
| 1626 Jeurgens Ct, Norcross, Georgia 30093 | |
| (770) 279-6200 |
| Name | Pruitthealth Nutritional Supp |
|---|---|
| Organization Name | Pruitthealth Nutritional Supply Inc |
| Location | 1626 Jeurgens Ct, Norcross, Georgia 30093 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (770) 279-6200 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
One problem that confounds researchers who are developing nanoparticles for use as cancer imaging and therapeutic agents is that many nanoparticles accumulate blood proteins on their surfaces as they circulate through the body.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets.
Burdened by budget deficits, states are cutting health programs to the chagrin of some. But others say the economic downturn has allowed states to take up long-term economic problems they wouldn't have addressed otherwise.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 3 days ago
| NPI Number | 1235186495 |
| Organization Name | PRUITTHEALTH NUTRITIONAL SUPPLY, INC. |
| Doing Business As | PRUITTHEALTH NUTRITIONAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1626 Jeurgens Court, Norcross, GA 30093 |
| Phone Number | 866-520-1214 |
News Archive
One problem that confounds researchers who are developing nanoparticles for use as cancer imaging and therapeutic agents is that many nanoparticles accumulate blood proteins on their surfaces as they circulate through the body.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets.
Burdened by budget deficits, states are cutting health programs to the chagrin of some. But others say the economic downturn has allowed states to take up long-term economic problems they wouldn't have addressed otherwise.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 3 days ago
| NPI Number | 1346385333 |
| Organization Name | PRUITTHEALTH PHARMACY SERVICES - ATLANTA, INC. |
| Doing Business As | PRUITTHEALTH PHARMACY SERVICES - ATLANTA |
| Type | Community/Retail Pharmacy |
| Address | 1626 Jeurgens Ct, Suite A, Norcross, GA 30093 |
| Phone Number | 678-533-6459 |
News Archive
One problem that confounds researchers who are developing nanoparticles for use as cancer imaging and therapeutic agents is that many nanoparticles accumulate blood proteins on their surfaces as they circulate through the body.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets.
Burdened by budget deficits, states are cutting health programs to the chagrin of some. But others say the economic downturn has allowed states to take up long-term economic problems they wouldn't have addressed otherwise.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 3 days ago
| NPI Number | 1700662442 |
| Organization Name | PRUITTHEALTH PHARMACY SERVICES - CHARLOTTE HALL, INC. |
| Type | Pharmacy |
| Address | 29449 Charlotte Hall Rd, Charlotte Hall, MD 20622 |
| Phone Number | 770-279-6200 |
News Archive
One problem that confounds researchers who are developing nanoparticles for use as cancer imaging and therapeutic agents is that many nanoparticles accumulate blood proteins on their surfaces as they circulate through the body.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets.
Burdened by budget deficits, states are cutting health programs to the chagrin of some. But others say the economic downturn has allowed states to take up long-term economic problems they wouldn't have addressed otherwise.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 3 days ago
News Archive
One problem that confounds researchers who are developing nanoparticles for use as cancer imaging and therapeutic agents is that many nanoparticles accumulate blood proteins on their surfaces as they circulate through the body.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
X-Chem, Inc. today announced the signing of a multi-year collaborative agreement with Roche to apply X-Chem's proprietary platform to the rapid discovery of drug candidates against several of Roche's high-value therapeutic targets.
Burdened by budget deficits, states are cutting health programs to the chagrin of some. But others say the economic downturn has allowed states to take up long-term economic problems they wouldn't have addressed otherwise.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported further progress in its continuing preclinical program of its CF602 drug candidate as the Company prepares to file an investigational new drug (IND) application with the U.S. Food and Drug Administration to allow the initiation of a Phase I clinical study.
› Verified 3 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 190 Technology Pkwy, Norcross, Georgia 30092 Phone: (800) 310-7995 | |
Advanced Home Infusion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5901 Goshen Springs Rd, Norcross, Georgia 30071 Phone: (770) 500-3834 | |
Cvs Pharmacy #02108 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5095 Peachtree Pkwy, Norcross, Georgia 30092 Phone: (770) 209-9299 | |
Cvs Pharmacy #02228 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5304 Buford Hwy, Norcross, Georgia 30071 Phone: (770) 209-0296 | |
Cvs Pharmacy #05646 Type: Medicare Supplier Location: 7734 Spalding Dr, Norcross, Georgia 30092 Phone: (770) 447-9096 |